Echo- Stress during Edge-to-Edge Mitral Valve Repair Can Be Useful

Transcatheter edge-to-edge mitral valve repair with Mitraclip has become a valid strategy to treat mitral valve regurgitation (MR) when surgery is not viable. However, after discharge, residual MR (>moderate) can affect over 10% of patients, because of the use of anesthesia, which alters pre and post procedural measurements. In this context, eco-stress could become a useful tool to identify patients presenting residual MR.

El eco-stress durante el tratamiento borde a borde puede ser útil

The study included 39 patients with severe MR undergoing edge-to-edge with MitraClip. After procedure, patients were tested with eco-stress with dobutamine under general anesthesia.

Mean age was 76, 39% were men, 36% hypertensive, 26% diabetic, 21% had prior MI, 23% PCI, 15% CABG, 54% atrial fibrillation, most were in functional class II-IV and most had high NT ProBNP.

Most patients received one or two clips.

By the end of procedure, 30 patients presented mild and moderate mitral valve regurgitation. 

After eco-stress with dobutamine, 11 patients saw increased MR. 6 presented >moderate.MR.

Read also: EuroPCR 2023 | ACURATE Neo2: Results After 5 Years.

Test diagnostic performance was established at 100% sensitivity and 85% specificity in unselected patients. 

Conclusion

The use of eco-stress during edge-to-edge can predict increased MR. In addition, it could support decision making during procedure, even when considering additional clips, and potentially improve evolution. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Dobutamine stress echocardiography during transcatheter edge‐to‐edge mitral valve repair predicts residual mitral regurgitation.

Reference: Frank Meijerink, et al. Catheter Cardiovasc Interv. 2023;101:1128–1133.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....